Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of TCN-202 (Human Anti-Cytomegalovirus Monoclonal Antibody) in Healthy Adult Volunteers

NCT01594437 is registered in ClinicalTrials.gov with Theraclone Sciences, Inc. as lead sponsor.

NCT NCT01594437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01594437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of TCN-202 (Human Anti-Cytomegalovirus Monoclonal Antibody) in Healthy Adult Volunteers
Lead sponsor
Theraclone Sciences, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2013
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections